Epigenetics Helps to Identify Immune Cells
DNA-methylation is an epigenetic phenomenon that drives cell-type specific gene expression. Epimune identifies DNA methylation markers that are specific for various different immune cell types.
Epimune Develops Real-Time PCR Tests for Immune Cell Specific DNA-Methylation Markers
Using real-time PCR technology Epimune's tests allow both relative (%) and absolute (cells/µl) quantification of immune cells from clinical samples
Epimune Provides Test Kits* to Selected Clinical Centers for Joint Clinical Validation
Epimune collaborates with leading clinical experts in the fields of Primary Immunodeficiency, Autoimmune Diseases, Transplantation, Immunology and Oncology. Please contact us if you are interested in collaborating with Epimune.
*Epimune's epigenetic immune cell quantification tests are for research use in collaborations with clinical experts and in the context of clinical studies, only. Epimune's test are not approved or cleared for diagnostic use and are not available for general research use.